Stock Scorecard
Stock Summary for Surgery Partners Inc (SGRY) - $22.40 as of 10/24/2025 6:24:26 PM EST
Total Score
4 out of 30
Safety Score
44 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for SGRY
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for SGRY
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for SGRY
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for SGRY
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for SGRY (44 out of 100)
| Stock Price Rating (Max of 10) | 7 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 5 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 4 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for SGRY
Financial Details for SGRY
Company Overview |
|
|---|---|
| Ticker | SGRY |
| Company Name | Surgery Partners Inc |
| Country | USA |
| Description | Surgery Partners, Inc. is a leading operator of surgical facilities and ancillary services across the United States, strategically headquartered in Brentwood, Tennessee. The company focuses on providing high-quality, cost-effective outpatient surgical care, leveraging a robust network of ambulatory surgery centers and associated services. With a commitment to enhancing patient outcomes and streamlining surgical processes, Surgery Partners is well-positioned to benefit from the growing demand for outpatient procedures in the evolving healthcare landscape. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL CARE FACILITIES |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 11/11/2025 |
Stock Price History |
|
| Last Day Price | 22.40 |
| Price 4 Years Ago | 53.41 |
| Last Day Price Updated | 10/24/2025 6:24:26 PM EST |
| Last Day Volume | 2,229,502 |
| Average Daily Volume | 1,266,663 |
| 52-Week High | 31.89 |
| 52-Week Low | 18.87 |
| Last Price to 52 Week Low | 18.71% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 28.59 |
| Sector PE | 41.12 |
| 5-Year Average PE | -22.28 |
| Free Cash Flow Ratio | 11.49 |
| Industry Free Cash Flow Ratio | 33.74 |
| Sector Free Cash Flow Ratio | 31.25 |
| Current Ratio Most Recent Quarter | 1.93 |
| Total Cash Per Share | 1.95 |
| Book Value Per Share Most Recent Quarter | 13.73 |
| Price to Book Ratio | 1.56 |
| Industry Price to Book Ratio | 18.22 |
| Sector Price to Book Ratio | 32.29 |
| Price to Sales Ratio Twelve Trailing Months | 0.84 |
| Industry Price to Sales Ratio Twelve Trailing Months | 1.19 |
| Sector Price to Sales Ratio Twelve Trailing Months | 16.43 |
| Analyst Buy Ratings | 8 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 128,209,000 |
| Market Capitalization | 2,871,881,600 |
| Institutional Ownership | 113.85% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -1,312.61% |
| Reported EPS 12 Trailing Months | -1.43 |
| Reported EPS Past Year | 0.21 |
| Reported EPS Prior Year | 0.50 |
| Net Income Twelve Trailing Months | -180,400,000 |
| Net Income Past Year | -168,100,000 |
| Net Income Prior Year | -11,900,000 |
| Quarterly Revenue Growth YOY | 8.40% |
| 5-Year Revenue Growth | 11.20% |
| Operating Margin Twelve Trailing Months | 14.70% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 250,100,000 |
| Total Cash Past Year | 269,500,000 |
| Total Cash Prior Year | 195,900,000 |
| Net Cash Position Most Recent Quarter | -3,215,100,000 |
| Net Cash Position Past Year | -2,999,400,000 |
| Long Term Debt Past Year | 3,268,900,000 |
| Long Term Debt Prior Year | 2,701,800,000 |
| Total Debt Most Recent Quarter | 3,465,200,000 |
| Equity to Debt Ratio Past Year | 0.35 |
| Equity to Debt Ratio Most Recent Quarter | 0.34 |
| Total Stockholder Equity Past Year | 1,789,700,000 |
| Total Stockholder Equity Prior Year | 1,987,200,000 |
| Total Stockholder Equity Most Recent Quarter | 1,748,300,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 175,300,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 1.37 |
| Free Cash Flow Past Year | 209,700,000 |
| Free Cash Flow Prior Year | 205,000,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.33 |
| MACD Signal | -0.39 |
| 20-Day Bollinger Lower Band | 19.62 |
| 20-Day Bollinger Middle Band | 21.81 |
| 20-Day Bollinger Upper Band | 24.00 |
| Beta | 1.84 |
| RSI | 46.91 |
| 50-Day SMA | 22.58 |
| 150-Day SMA | 28.54 |
| 200-Day SMA | 31.09 |
System |
|
| Modified | 10/23/2025 9:10:50 AM EST |